Organovo Holdings (ONVO) 6.69 $ONVO
3D printing stocks hit hard
Seeking Alpha - at Seeking Alpha - 1 hr 23 mins ago
ARCW: 8.41 (-0.62), VJET: 7.54 (-0.32), ONVO: 6.69 (-0.33), DDD: 31.36 (-1.27), SSYS: 75.65 (-2.11), XONE: 15.65 (-0.88)
Today's Review on Biotech Equities - Kite Pharma, Organovo Holdings, BioMarin Pharma, NephroGenex, and Neuralstem
PR Newswire - Fri Jan 09, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: Kite Pharma Inc. (NASDAQ: KITE), Organovo Holdings Inc. (NYSE MKT: ONVO), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), NephroGenex Inc. (NASDAQ: NRX), and Neuralstem Inc. (NYSE MKT: CUR). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets surged on Thursday, January 08, 2015, as the Dow Jones Industrial Average finished at 17,907.87, up 1.84% and the NASDAQ Composite closed at 4,736.19, up 1.84%. The S&P 500 finished the session 1.79% higher at 2,062.14. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 819.86, up 1.72%, with the index gaining 11.71% in the previous three months. Register for your complimentary reports on these five stocks at:
BMRN: 96.58 (+2.80), KITE: 82.35 (+3.21), ONVO: 6.69 (-0.33), NRX: 7.90 (-1.19), CUR: 3.22 (-0.18)
Why Organovo Holdings Inc. Stock Launched 15% Higher in December
Sean Williams, The Motley Fool - Motley Fool - Thu Jan 08, 12:03PM CST
What: Shares of Organovo Holdings , a tissue engineering company focused on providing functional human tissue models and solutions to aid in the drug discovery process, rocketed higher by 15% in December, based on data from S&P Capital IQ ,...
ONVO: 6.69 (-0.33)
Could Yale University and Organovo Solve This Big Problem?
Todd Campbell, The Motley Fool - Motley Fool - Sat Jan 03, 8:44AM CST
Source: Organovo Holdings. In early December, Yale University's medical school announced that it was teaming up with Organovo Holdings on a project that could someday offer hope to thousands of transplant patients. Yale University's School of...
ONVO: 6.69 (-0.33)
Seeking Alpha's Biotech Weekly: 2014's Approval-Palooza, Ebola In Scotland, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Jan 02, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
ACC: 43.44 (+0.40), JNJ: 104.58 (-0.36), NVO: 43.70 (+0.49), OGXI: 2.30 (+0.01), GILD: 101.21 (-1.00), ONVO: 6.69 (-0.33), TKMR: 24.68 (+8.98), TEVA: 57.01 (+0.29), MDXG: 8.79 (-0.48)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 4:50PM CST
INSY: 48.39 (+2.80), DNOW: 22.94 (-0.88), MTRX: 18.34 (-0.92), RDNT: 8.85 (+0.53), ONVO: 6.69 (-0.33), PES: 4.58 (-0.38), RUSS: 25.68 (+2.28), CEMP: 26.62 (+0.84), LPI: 8.68 (-0.72), HTA: 28.62 (-0.08)
Organovo sets up $33M equity sales agreement
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 6:07AM CST
ONVO: 6.69 (-0.33)
Is Organovo Coming of Age?
Todd Campbell, The Motley Fool - Motley Fool - Mon Dec 29, 2:52PM CST
Source: Organovo Long term investors hope that the launch of Organovo 's exVive3D Human Liver Model marks a significant turning point for the company. After years of research into developing bioprinting technology to create 3D liver tissue...
ONVO: 6.69 (-0.33)
First Week Of August 2015 Options Trading For Organovo Holdings
at The Street - Fri Dec 26, 10:52AM CST
Investors in Organovo Holdings Inc saw new options become available this week, for the August 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the...
ONVO: 6.69 (-0.33)
'Mad Money' Lightning Round: Enbridge Energy Partners Is a Great Stock
at The Street - Wed Dec 17, 5:00AM CST
Cramer says to wait on buying Chevron and Bluebird Bio until their shares are lower and stay away from EV Energy Partners.
BLUE: 101.95 (-1.68), TTWO: 27.87 (unch), ATVI: 18.86 (-0.04), SAIC: 49.13 (-0.11), EVEP: 16.90 (-1.64), ONVO: 6.69 (-0.33), TRN: 25.93 (-0.95), CVX: 105.88 (-2.33), EEP: 38.54 (-0.69)
Cramer's Lightning Round - Chevron Is Worth The Wait (12/16/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Dec 17, 4:03AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday December 16. Bullish Calls: Chevron (NYSE: CVX ): "CVX has a nice yield and it is good. You are going to have to wait till around $95 with a...
BLUE: 101.95 (-1.68), ATVI: 18.86 (-0.04), SAIC: 49.13 (-0.11), EVEP: 16.90 (-1.64), ONVO: 6.69 (-0.33), TRN: 25.93 (-0.95), CVX: 105.88 (-2.33), EEP: 38.54 (-0.69)
Jim Cramer's 'Mad Money' Recap: Goldilocks vs. 3 Bears, Where Nothing Is Just Right
at The Street - Tue Dec 16, 7:10PM CST
The bears may have won the day but there's still hope, Cramer says.
BLUE: 101.95 (-1.68),
76.50 (unch), RH: 94.14 (+0.52), COLM: 44.02 (+0.28), EEP: 38.54 (-0.69), TTWO: 27.87 (unch), ATVI: 18.86 (-0.04), PBR: 6.57 (-0.49), SAIC: 49.13 (-0.11), EVEP: 16.90 (-1.64), ONVO: 6.69 (-0.33), TRN: 25.93 (-0.95), CVX: 105.88 (-2.33)
Strong On High Relative Volume: Organovo Holdings (ONVO)
at The Street - Mon Dec 15, 9:00AM CST
Trade-Ideas LLC identified Organovo Holdings (ONVO) as a strong on high relative volume candidate
ONVO: 6.69 (-0.33)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 8:12AM CST
FRO: 4.63 (+0.69), TLM: 7.50 (-0.11), SPHS: 0.47 (unch), HGSH: 3.88 (+0.02), SN: 8.56 (-0.32), NBG: 1.66 (+0.09), AXAS: 2.69 (-0.21), RVBD: 20.55 (-0.01), OPK: 10.27 (+0.17), ANTH: 2.48 (-0.15), ONVO: 6.69 (-0.33), KEG: 1.34 (-0.10), CALA: 22.86 (-0.78), XCO: 1.88 (-0.02), CRUS: 23.55 (-0.10), ARCP: 9.44 (-0.06)
Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product
PR Newswire - Mon Dec 15, 7:05AM CST
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
, a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today celebrated continued positive reception by the industry and collaborators of its exVive3DTM Human Liver Tissue. The product, which was made widely available in full commercial release on November 18, has been recognized as groundbreaking in the field, resulting in several awards for innovation.
ONVO: 6.69 (-0.33)
The 2 Things Organovo Holdings Inc Stock Shareholders Must Know Heading into 2015
Brian Stoffel, The Motley Fool - Motley Fool - Fri Dec 12, 4:40PM CST
Shareholders of Organovo know that the ride for this company's stock is always going to be bumpy. For a long time, in fact, there wasn't even a marketable product the 3-D bioprinting company was offering—just the hope of one. That all changed a...
ONVO: 6.69 (-0.33)
Organovo set for modest gap up at the open
Seeking Alpha - at Seeking Alpha - Fri Dec 12, 8:03AM CST
ONVO: 6.69 (-0.33)
These Headwinds Make Organovo A Short Candidate
Akshansh Gandhi - at Seeking Alpha - Wed Dec 10, 1:39PM CST
ONVO: 6.69 (-0.33)
3D Printing Material Market (Metals, Alloys, ABS, PLA, Photopolymer, Ceramics etc.), Technology, Application (Medical, Aerospace & Defense, Automotive & Others) Markets - A Global Study (2014-2022)
M2 - Tue Dec 09, 8:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/vr5hqx/3d_printing) has announced the addition of the "3D Printing Material Market (Metals, Alloys, ABS, PLA, Photopolymer, Ceramics etc.), Technology, Application (Medical, Aerospace & Defense, Automotive & Others) Markets - A Global Study (2014-2022)" report to their offering. Materials are to 3D printing what software is to information technology. The market for 3D printing material is evolving at a rapid pace. During 2014, there has been a significant breakthrough across material technologies being used in additive manufacturing. Until 2012 most of the 3D printers used either plastics or photopolymers, however, by 2014 we have a plethora of materials to choose from including various metals and alloys. This study identifies key materials being used in the existing 3D printers across various technologies, and applications. The market size estimates, technological advancements, and various use cases, along with key players across each materials are covered with granular details. The report covers more than 50 players involved in the 3D printing and Additive Manufacturing technology market. The Technology Analysis chapter provides detailed insights into existing 3D printing technologies such as FDM, SLS, 3DP, SLA, PJM, EBM, and Multijet modeling, among others. The information supplied in the chapter includes market players, market size, materials used, and growth opportunities, along with technology lifecycle analysis Key Topics Covered: 1 REPORT SCOPE 2 MARKET OVERVIEW 3 TECHNOLOGY MARKET 4 MATERIALS MARKET 5 Industrial Analysis 6 Competitive Landscape 7 Company Profiles Companies Mentioned: - 3d Systems - 3t Rpd Ltd. - Arcam Ab - Biomedical Modeling Inc - Ceradrop Mgi Group - Concept Laser - Dassault Syst?mes - Envisiontec - Eos Gmbh Electro Optical Systems - Exone - Ge Aviation - Gpi Prototype & Manufacturing Services, Inc. - H?gan?s Ab - Koninklijke Dsm Nv - Layerwise Nv - Luxexcel Group B.V. - Mcor Technologies Ltd. - Medical Modeling - Microtec Gesellschaft F?r Mikrotechnologie Mbh - Optomec - Organovo Holdings - Renishaw, Plc - Sciaky Summary - Slm Solutions Gmbh - Stratasys - Voxeljet - Zortrax For more information visit http://www.researchandmarkets.com/research/vr...d_printing
ONVO: 6.69 (-0.33), SSYS: 75.65 (-2.11)
3D printing stocks hit hard
Seeking Alpha - at Seeking Alpha - 1 hr 23 mins ago
ARCW: 8.41 (-0.62), VJET: 7.54 (-0.32), ONVO: 6.69 (-0.33), DDD: 31.36 (-1.27), SSYS: 75.65 (-2.11), XONE: 15.65 (-0.88)
Today's Review on Biotech Equities - Kite Pharma, Organovo Holdings, BioMarin Pharma, NephroGenex, and Neuralstem
PR Newswire - Fri Jan 09, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: Kite Pharma Inc. (NASDAQ: KITE), Organovo Holdings Inc. (NYSE MKT: ONVO), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), NephroGenex Inc. (NASDAQ: NRX), and Neuralstem Inc. (NYSE MKT: CUR). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets surged on Thursday, January 08, 2015, as the Dow Jones Industrial Average finished at 17,907.87, up 1.84% and the NASDAQ Composite closed at 4,736.19, up 1.84%. The S&P 500 finished the session 1.79% higher at 2,062.14. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 819.86, up 1.72%, with the index gaining 11.71% in the previous three months. Register for your complimentary reports on these five stocks at:
BMRN: 96.58 (+2.80), KITE: 82.35 (+3.21), ONVO: 6.69 (-0.33), NRX: 7.90 (-1.19), CUR: 3.22 (-0.18)
Why Organovo Holdings Inc. Stock Launched 15% Higher in December
Sean Williams, The Motley Fool - Motley Fool - Thu Jan 08, 12:03PM CST
What: Shares of Organovo Holdings , a tissue engineering company focused on providing functional human tissue models and solutions to aid in the drug discovery process, rocketed higher by 15% in December, based on data from S&P Capital IQ ,...
ONVO: 6.69 (-0.33)
Could Yale University and Organovo Solve This Big Problem?
Todd Campbell, The Motley Fool - Motley Fool - Sat Jan 03, 8:44AM CST
Source: Organovo Holdings. In early December, Yale University's medical school announced that it was teaming up with Organovo Holdings on a project that could someday offer hope to thousands of transplant patients. Yale University's School of...
ONVO: 6.69 (-0.33)
Seeking Alpha's Biotech Weekly: 2014's Approval-Palooza, Ebola In Scotland, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Jan 02, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
ACC: 43.44 (+0.40), JNJ: 104.58 (-0.36), NVO: 43.70 (+0.49), OGXI: 2.30 (+0.01), GILD: 101.21 (-1.00), ONVO: 6.69 (-0.33), TKMR: 24.68 (+8.98), TEVA: 57.01 (+0.29), MDXG: 8.79 (-0.48)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 4:50PM CST
INSY: 48.39 (+2.80), DNOW: 22.94 (-0.88), MTRX: 18.34 (-0.92), RDNT: 8.85 (+0.53), ONVO: 6.69 (-0.33), PES: 4.58 (-0.38), RUSS: 25.68 (+2.28), CEMP: 26.62 (+0.84), LPI: 8.68 (-0.72), HTA: 28.62 (-0.08)
Organovo sets up $33M equity sales agreement
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 6:07AM CST
ONVO: 6.69 (-0.33)
Is Organovo Coming of Age?
Todd Campbell, The Motley Fool - Motley Fool - Mon Dec 29, 2:52PM CST
Source: Organovo Long term investors hope that the launch of Organovo 's exVive3D Human Liver Model marks a significant turning point for the company. After years of research into developing bioprinting technology to create 3D liver tissue...
ONVO: 6.69 (-0.33)
First Week Of August 2015 Options Trading For Organovo Holdings
at The Street - Fri Dec 26, 10:52AM CST
Investors in Organovo Holdings Inc saw new options become available this week, for the August 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the...
ONVO: 6.69 (-0.33)
'Mad Money' Lightning Round: Enbridge Energy Partners Is a Great Stock
at The Street - Wed Dec 17, 5:00AM CST
Cramer says to wait on buying Chevron and Bluebird Bio until their shares are lower and stay away from EV Energy Partners.
BLUE: 101.95 (-1.68), TTWO: 27.87 (unch), ATVI: 18.86 (-0.04), SAIC: 49.13 (-0.11), EVEP: 16.90 (-1.64), ONVO: 6.69 (-0.33), TRN: 25.93 (-0.95), CVX: 105.88 (-2.33), EEP: 38.54 (-0.69)
Cramer's Lightning Round - Chevron Is Worth The Wait (12/16/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Dec 17, 4:03AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday December 16. Bullish Calls: Chevron (NYSE: CVX ): "CVX has a nice yield and it is good. You are going to have to wait till around $95 with a...
BLUE: 101.95 (-1.68), ATVI: 18.86 (-0.04), SAIC: 49.13 (-0.11), EVEP: 16.90 (-1.64), ONVO: 6.69 (-0.33), TRN: 25.93 (-0.95), CVX: 105.88 (-2.33), EEP: 38.54 (-0.69)
Jim Cramer's 'Mad Money' Recap: Goldilocks vs. 3 Bears, Where Nothing Is Just Right
at The Street - Tue Dec 16, 7:10PM CST
The bears may have won the day but there's still hope, Cramer says.
BLUE: 101.95 (-1.68),
76.50 (unch), RH: 94.14 (+0.52), COLM: 44.02 (+0.28), EEP: 38.54 (-0.69), TTWO: 27.87 (unch), ATVI: 18.86 (-0.04), PBR: 6.57 (-0.49), SAIC: 49.13 (-0.11), EVEP: 16.90 (-1.64), ONVO: 6.69 (-0.33), TRN: 25.93 (-0.95), CVX: 105.88 (-2.33) Strong On High Relative Volume: Organovo Holdings (ONVO)
at The Street - Mon Dec 15, 9:00AM CST
Trade-Ideas LLC identified Organovo Holdings (ONVO) as a strong on high relative volume candidate
ONVO: 6.69 (-0.33)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 8:12AM CST
FRO: 4.63 (+0.69), TLM: 7.50 (-0.11), SPHS: 0.47 (unch), HGSH: 3.88 (+0.02), SN: 8.56 (-0.32), NBG: 1.66 (+0.09), AXAS: 2.69 (-0.21), RVBD: 20.55 (-0.01), OPK: 10.27 (+0.17), ANTH: 2.48 (-0.15), ONVO: 6.69 (-0.33), KEG: 1.34 (-0.10), CALA: 22.86 (-0.78), XCO: 1.88 (-0.02), CRUS: 23.55 (-0.10), ARCP: 9.44 (-0.06)
Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product
PR Newswire - Mon Dec 15, 7:05AM CST
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
, a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today celebrated continued positive reception by the industry and collaborators of its exVive3DTM Human Liver Tissue. The product, which was made widely available in full commercial release on November 18, has been recognized as groundbreaking in the field, resulting in several awards for innovation. ONVO: 6.69 (-0.33)
The 2 Things Organovo Holdings Inc Stock Shareholders Must Know Heading into 2015
Brian Stoffel, The Motley Fool - Motley Fool - Fri Dec 12, 4:40PM CST
Shareholders of Organovo know that the ride for this company's stock is always going to be bumpy. For a long time, in fact, there wasn't even a marketable product the 3-D bioprinting company was offering—just the hope of one. That all changed a...
ONVO: 6.69 (-0.33)
Organovo set for modest gap up at the open
Seeking Alpha - at Seeking Alpha - Fri Dec 12, 8:03AM CST
ONVO: 6.69 (-0.33)
These Headwinds Make Organovo A Short Candidate
Akshansh Gandhi - at Seeking Alpha - Wed Dec 10, 1:39PM CST
ONVO: 6.69 (-0.33)
3D Printing Material Market (Metals, Alloys, ABS, PLA, Photopolymer, Ceramics etc.), Technology, Application (Medical, Aerospace & Defense, Automotive & Others) Markets - A Global Study (2014-2022)
M2 - Tue Dec 09, 8:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/vr5hqx/3d_printing) has announced the addition of the "3D Printing Material Market (Metals, Alloys, ABS, PLA, Photopolymer, Ceramics etc.), Technology, Application (Medical, Aerospace & Defense, Automotive & Others) Markets - A Global Study (2014-2022)" report to their offering. Materials are to 3D printing what software is to information technology. The market for 3D printing material is evolving at a rapid pace. During 2014, there has been a significant breakthrough across material technologies being used in additive manufacturing. Until 2012 most of the 3D printers used either plastics or photopolymers, however, by 2014 we have a plethora of materials to choose from including various metals and alloys. This study identifies key materials being used in the existing 3D printers across various technologies, and applications. The market size estimates, technological advancements, and various use cases, along with key players across each materials are covered with granular details. The report covers more than 50 players involved in the 3D printing and Additive Manufacturing technology market. The Technology Analysis chapter provides detailed insights into existing 3D printing technologies such as FDM, SLS, 3DP, SLA, PJM, EBM, and Multijet modeling, among others. The information supplied in the chapter includes market players, market size, materials used, and growth opportunities, along with technology lifecycle analysis Key Topics Covered: 1 REPORT SCOPE 2 MARKET OVERVIEW 3 TECHNOLOGY MARKET 4 MATERIALS MARKET 5 Industrial Analysis 6 Competitive Landscape 7 Company Profiles Companies Mentioned: - 3d Systems - 3t Rpd Ltd. - Arcam Ab - Biomedical Modeling Inc - Ceradrop Mgi Group - Concept Laser - Dassault Syst?mes - Envisiontec - Eos Gmbh Electro Optical Systems - Exone - Ge Aviation - Gpi Prototype & Manufacturing Services, Inc. - H?gan?s Ab - Koninklijke Dsm Nv - Layerwise Nv - Luxexcel Group B.V. - Mcor Technologies Ltd. - Medical Modeling - Microtec Gesellschaft F?r Mikrotechnologie Mbh - Optomec - Organovo Holdings - Renishaw, Plc - Sciaky Summary - Slm Solutions Gmbh - Stratasys - Voxeljet - Zortrax For more information visit http://www.researchandmarkets.com/research/vr...d_printing
ONVO: 6.69 (-0.33), SSYS: 75.65 (-2.11)
